MENU
+Compare
NRXS
Stock ticker: ASE
AS OF
Jun 13, 04:59 PM (EDT)
Price
$2.28
Change
-$0.02 (-0.87%)
Capitalization
21.91M

NRXS Neuraxis Forecast, Technical & Fundamental Analysis

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more

NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NRXS with price predictions
Jun 12, 2025

NRXS's Stochastic Oscillator stays in oversold zone for 13 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +7 3-day Advance, the price is estimated to grow further. Considering data from situations where NRXS advanced for three days, in of 74 cases, the price rose further within the following month. The odds of a continued upward trend are .

NRXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 31 cases where NRXS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NRXS moved out of overbought territory on May 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 3 similar instances where the indicator moved out of overbought territory. In of the 3 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NRXS as a result. In of 36 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NRXS turned negative on June 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .

NRXS moved below its 50-day moving average on June 12, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRXS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (86.207) is normal, around the industry mean (16.730). P/E Ratio (0.000) is within average values for comparable stocks, (59.666). NRXS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.336). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (5.602) is also within normal values, averaging (257.556).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NRXS is expected to report earnings to fall 34.78% to -15 cents per share on April 09

Neuraxis NRXS Stock Earnings Reports
Q4'23
Est.
$-0.15
Q4'24
Missed
by $0.27
Q1'24
Missed
by $0.22
Q3'23
Missed
by $1.18
The last earnings report on March 20 showed earnings per share of -23 cents, missing the estimate of 3 cents. With 48.59K shares outstanding, the current market capitalization sits at 21.91M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPH31.250.15
+0.48%
Tri Pointe Homes
VIVK0.86N/A
+0.26%
Vivakor
CRGX4.48-0.01
-0.22%
CARGO Therapeutics
TROW94.58-0.52
-0.55%
T Rowe Price Group
OPK1.34-0.01
-0.74%
OPKO Health

NRXS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-7.63%
CVM - NRXS
59%
Loosely correlated
-4.44%
BTAI - NRXS
27%
Poorly correlated
-1.12%
CTMX - NRXS
25%
Poorly correlated
+6.03%
ALT - NRXS
24%
Poorly correlated
+9.33%
MRVI - NRXS
24%
Poorly correlated
-0.88%
More